Palisade Bio (PALI) Restructuring Costs (2013 - 2026)

Palisade Bio (PALI) has 4 years of Restructuring Costs data on file, last reported at $4.2 million in Q1 2026.

• On a quarterly basis, Restructuring Costs rose 213.14% year-over-year to $4.2 million in Q1 2026; TTM through Mar 2026 was $10.5 million, a 91.8% increase from a year earlier, with the FY2025 full-year figure at $7.6 million, up 38.37% from the prior year.
• Restructuring Costs for Q1 2026 stood at $4.2 million, up from $3.6 million in the prior quarter.
• Over the last five years, Restructuring Costs for PALI reached as high as $4.2 million in Q1 2026 and fell as low as $1.1 million in Q2 2025.
• Historically, Restructuring Costs has averaged $1.9 million across 3 years, with a median of $1.4 million in 2024.
• Across the five-year window, Restructuring Costs dropped 22.6% in 2025 and soared 213.14% in 2026, its largest moves.
• Year by year, Restructuring Costs stood at $1.4 million in 2024, then surged by 158.13% to $3.6 million in 2025, then rose by 18.15% to $4.2 million in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were $4.2 million in Q1 2026, $3.6 million in Q4 2025, and $1.5 million in Q3 2025.